2022³â 2ȸ ´ëÇѳ»ºÐºñÇÐȸ ³²¼ºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2022-08-13±³À°ÀÏÀÚ : 2022-08-13
±³À°Àå¼Ò : ¼ö¿øÄÁº¥¼Ç¼¾ÅÍ 2Ãþ 207È£
±³À°ÁÖÁ¦ :
2022³â 2ȸ ´ëÇѳ»ºÐºñÇÐȸ ³²¼ºÈ£¸£¸ó¿¬±¸È¸ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ³²¼ºÈ£¸£¸ó¿¬±¸È¸
´ã´çÀÚ : ³²¼ºÈ£¸£¸ó¿¬±¸È¸ »ç¹«±¹
¿¬¶ôó : 031-705-0549
À̸ÞÀÏ :
pnbbio@pnbbio.com ±³À°Á¾·ù : ³»°ú, ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í *»çÀüµî·Ï: Àü¹®ÀÇ(30,000), Àü°øÀÇ,¿¬±¸¿ø,°£È£»ç(10,000), Çлý(¹«·á)*ÇöÀåµî·Ï: Àü¹®ÀÇ50,000), Àü°øÀÇ,¿¬±¸¿ø, °£È£»ç(20,000), Çлý(¹«·á)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-13 207È£ 09:00~09:30 Establishing reference intervals of androgens in men ÀÌÁØÈ£(À»Áö´ëÀÇ´ë, ºñ´¢±â°ú)
±³À°½Ã°£ 08-13 207È£ 09:30~10:00 Applicability of immunoassay and mass spectrometry in steroid analysis ÃÖ¸¸È£(KIST(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø))
ÈÞ½Ä 08-13 207È£ 10:00~10:10 Coffee break ()
±³À°½Ã°£ 08-13 207È£ 10:10~10:40 Diagnosis of male hypogonadism ¼¼ºÈ¯(µ¿¾Æ´ëÀÇ´ë, ³»ºÐºñ³»°ú)
±³À°½Ã°£ 08-13 207È£ 10:40~11:10 Practical testosterone replacement therapy ¾È¼øÅÂ(°í·Á´ëÀÇ´ë, ºñ´¢±â°ú)
±³À°½Ã°£ 08-13 207È£ 11:10~11:50 Androgens, cardiometabolic disease and mortality in men Yeap Bu Beng(Dept. of Endocrinology and Diabetes, Univ. of Western Australia, Australia)
±³À°½Ã°£ 08-13 207È£ 11:50~12:10 Testosterone intranasal Ranjith Ramasamy(Dept. of Urology, Univ. of Miami, USA)
½Ä»ç 08-13 207È£ 12:10~12:40 Lunch ()
±³À°½Ã°£ 08-13 207È£ 12:40~13:10 Role of estrogen receptor in Leydig cells °è¸íÂù(ÇѾç´ë. »ý¸í°úÇаú)
±³À°½Ã°£ 08-13 207È£ 13:10~13:50 Anabolic steroid withdrawal hypogonadism Yeap Bu Beng(Dept. of Endocrinology and Diabetes, Univ. of Western Australia, Australia)
ÈÞ½Ä 08-13 207È£ 13:50~14:00 Coffee break ()
±³À°½Ã°£ 08-13 207È£ 14:00~14:30 Metabolic changes of CAH in steroidogenesis ±èÁ¤Èñ(¼¿ï´ëÀÇ´ë, ³»ºÐºñ´ë»ç³»°ú)
±³À°½Ã°£ 08-13 207È£ 14:30~15:00 Clinical and genetic heterogeneity of congenital adrenal hyperplasia ÃÖÁøÈ£(¿ï»ê´ëÀÇ´ë, ¼Ò¾Æ³»ºÐºñ´ë»ç°ú)